269 related articles for article (PubMed ID: 19857988)
1. Solubility, spectroscopic properties and photostability of Rhein/cyclodextrin inclusion complex.
Petralito S; Zanardi I; Memoli A; Annesini MC; Travagli V
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Dec; 74(5):1254-9. PubMed ID: 19857988
[TBL] [Abstract][Full Text] [Related]
2. Inclusion complexes of tadalafil with natural and chemically modified beta-cyclodextrins. I: preparation and in-vitro evaluation.
Badr-Eldin SM; Elkheshen SA; Ghorab MM
Eur J Pharm Biopharm; 2008 Nov; 70(3):819-27. PubMed ID: 18655829
[TBL] [Abstract][Full Text] [Related]
3. Dissolution properties and characterization of halofantrine-2-hydroxypropyl-beta-cyclodextrin binary systems.
Onyeji CO; Omoruyi SI; Oladimeji FA
Pharmazie; 2007 Nov; 62(11):858-63. PubMed ID: 18065103
[TBL] [Abstract][Full Text] [Related]
4. The inclusion complexes of hesperetin and its 7-rhamnoglucoside with (2-hydroxypropyl)-beta-cyclodextrin.
Tommasini S; Calabrò ML; Stancanelli R; Donato P; Costa C; Catania S; Villari V; Ficarra P; Ficarra R
J Pharm Biomed Anal; 2005 Sep; 39(3-4):572-80. PubMed ID: 15985355
[TBL] [Abstract][Full Text] [Related]
5. Inclusion complexes of pyrimethamine in 2-hydroxypropyl-beta-cyclodextrin: characterization, phase solubility and molecular modelling.
de Araújo MV; Vieira EK; Lázaro GS; de Souza Conegero L; Ferreira OP; Almeida LS; Barreto LS; da Costa NB; Gimenez IF
Bioorg Med Chem; 2007 Sep; 15(17):5752-9. PubMed ID: 17583516
[TBL] [Abstract][Full Text] [Related]
6. Formation of natamycin:cyclodextrin inclusion complexes and their characterization.
Koontz JL; Marcy JE
J Agric Food Chem; 2003 Nov; 51(24):7106-10. PubMed ID: 14611179
[TBL] [Abstract][Full Text] [Related]
7. Preparation and spectral investigation of inclusion complex of caffeic acid with hydroxypropyl-beta-cyclodextrin.
Zhang M; Li J; Zhang L; Chao J
Spectrochim Acta A Mol Biomol Spectrosc; 2009 Jan; 71(5):1891-5. PubMed ID: 18722807
[TBL] [Abstract][Full Text] [Related]
8. Characterization of the 13-cis-retinoic acid/cyclodextrin inclusion complexes by phase solubility, photostability, physicochemical and computational analysis.
Yap KL; Liu X; Thenmozhiyal JC; Ho PC
Eur J Pharm Sci; 2005 May; 25(1):49-56. PubMed ID: 15854800
[TBL] [Abstract][Full Text] [Related]
9. Comparative study on the inclusion behavior between meso-tetrakis(4-N-ethylpyridiniurmyl)porphyrin and beta-cyclodextrin derivatives.
Xiliang G; Shaomin S; Chuan D; Feng F; Wong MS
Spectrochim Acta A Mol Biomol Spectrosc; 2005 Jan; 61(3):413-8. PubMed ID: 15582808
[TBL] [Abstract][Full Text] [Related]
10. UV-vis and FTIR-ATR characterization of 9-fluorenon-2-carboxyester/(2-hydroxypropyl)-beta-cyclodextrin inclusion complex.
Stancanelli R; Ficarra R; Cannavà C; Guardo M; Calabrò ML; Ficarra P; Ottanà R; Maccari R; Crupi V; Majolino D; Venuti V
J Pharm Biomed Anal; 2008 Aug; 47(4-5):704-9. PubMed ID: 18400444
[TBL] [Abstract][Full Text] [Related]
11. Study of the interaction between hydroxymethylnitrofurazone and 2-hydroxypropyl-beta-cyclodextrin.
Grillo R; de Melo NF; Moraes CM; de Lima R; Menezes CM; Ferreira EI; Rosa AH; Fraceto LF
J Pharm Biomed Anal; 2008 Jun; 47(2):295-302. PubMed ID: 18289821
[TBL] [Abstract][Full Text] [Related]
12. Complexation of morin with three kinds of cyclodextrin. A thermodynamic and reactivity study.
Jullian C; Orosteguis T; Pérez-Cruz F; Sánchez P; Mendizabal F; Olea-Azar C
Spectrochim Acta A Mol Biomol Spectrosc; 2008 Nov; 71(1):269-75. PubMed ID: 18262835
[TBL] [Abstract][Full Text] [Related]
13. Lumichrome complexation by cyclodextrins: influence of pharmaceutical excipients.
Lilletvedt M; Kristensen S; Tønnesen HH
Pharmazie; 2010 Dec; 65(12):871-6. PubMed ID: 21284255
[TBL] [Abstract][Full Text] [Related]
14. UV-vis and FTIR-ATR spectroscopic techniques to study the inclusion complexes of genistein with beta-cyclodextrins.
Crupi V; Ficarra R; Guardo M; Majolino D; Stancanelli R; Venuti V
J Pharm Biomed Anal; 2007 May; 44(1):110-7. PubMed ID: 17379467
[TBL] [Abstract][Full Text] [Related]
15. Fosinopril-cyclodextrin inclusion complexes: phase solubility and physicochemical analysis.
Sbârcea L; Udrescu L; Drăgan L; Trandafirescu C; Szabadai Z; Bojiţă M
Pharmazie; 2011 Aug; 66(8):584-9. PubMed ID: 21901980
[TBL] [Abstract][Full Text] [Related]
16. Physicochemical characteristics and bioavailability of a novel intestinal metabolite of ginseng saponin (IH901) complexed with beta-cyclodextrin.
Lee PS; Han JY; Song TW; Sung JH; Kwon OS; Song S; Chung YB
Int J Pharm; 2006 Jun; 316(1-2):29-36. PubMed ID: 16574357
[TBL] [Abstract][Full Text] [Related]
17. Cyclodextrin-enhanced solubilization of pentachlorophenol in water.
Hanna K; de Brauer Ch; Germain P
J Environ Manage; 2004 May; 71(1):1-8. PubMed ID: 15084354
[TBL] [Abstract][Full Text] [Related]
18. Fluorimetric investigation of supramolecular system by modified β-cyclodextrin and its analytical application.
Huang L; He J; Ge X; Lu R; Guo J
Spectrochim Acta A Mol Biomol Spectrosc; 2011 May; 78(5):1553-9. PubMed ID: 21339082
[TBL] [Abstract][Full Text] [Related]
19. Effect of 2-hydroxypropyl-beta-cyclodextrin on the solubility, stability, and pharmacological activity of the chemical delivery system of TRH analogs.
Wu WM; Wu J; Bodor N
Pharmazie; 2002 Feb; 57(2):130-4. PubMed ID: 11878189
[TBL] [Abstract][Full Text] [Related]
20. Preparation and characterization of simvastatin/hydroxypropyl-beta-cyclodextrin inclusion complex using supercritical antisolvent (SAS) process.
Jun SW; Kim MS; Kim JS; Park HJ; Lee S; Woo JS; Hwang SJ
Eur J Pharm Biopharm; 2007 Jun; 66(3):413-21. PubMed ID: 17240129
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]